Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leukemia in pediatric age]

L Massimo, C Micalizzi, G Dini

    Minerva Pediatrica
    |January 1, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Childhood leukemia prognosis has significantly improved due to advanced clinical trials and risk-factor-based treatments. Modern "total therapy" eradicates cancer cells while supporting patients psychologically and socially.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Condylomata Lata and Papular Rash of Secondary Syphilis.

    Actas dermo-sifiliograficas·2023
    Same author

    Condylomata Lata and Papular Rash of Secondary Syphilis.

    Actas dermo-sifiliograficas·2022
    Same author

    New-onset vitiligo following COVID-19 disease.

    Skin health and disease·2022
    Same author

    Dermoscopy of papulopustular rosacea and comparison of dermoscopic features in patients with or without concomitant Demodex folliculorum.

    Clinical and experimental dermatology·2021
    Same author

    Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: the role of mycophenolate mofetil.

    Blood advances·2019
    Same author

    Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors.

    Journal of preventive medicine and hygiene·2019
    Same journal

    Developmental and behavioral profile in a domestic adoptees sample: a new challenge for the pediatrician.

    Minerva pediatrica·2020
    Same journal

    A new approach to the diagnosis of short stature.

    Minerva pediatrica·2020
    Same journal

    Management of the main endocrine and diabetic disorders in children.

    Minerva pediatrica·2020
    Same journal

    Kounis Syndrome: a pediatric perspective.

    Minerva pediatrica·2020
    Same journal

    Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane.

    Minerva pediatrica·2020
    Same journal

    Tall stature in children and adolescents.

    Minerva pediatrica·2020
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Hematology
    • Cancer Research

    Context:

    • Childhood leukemia outcomes have dramatically improved over the past two decades.
    • Advances are driven by prospective clinical investigations and personalized risk-factor assessment.
    • The review encompasses a comprehensive overview of childhood leukemia.

    Purpose:

    • To review the epidemiology, classification, and laboratory findings of childhood leukemia.
    • To discuss clinical manifestations, differential diagnosis, and prognostic factors.
    • To explore modern treatment strategies, including total therapy and bone marrow transplantation.

    Summary:

    • Childhood leukemia treatment has evolved through optimized combination chemotherapy and risk stratification.
    • Laboratory findings include morphology, cytochemistry, immunophenotyping, cytogenetics, and molecular biology.

    Related Experiment Videos

  • Total therapy integrates eradicating leukemic cells with preserving normal progenitors and addressing psychosocial needs.
  • Impact:

    • Improved survival rates and quality of life for children with leukemia.
    • Highlights the importance of multidisciplinary care, including psychological and social support.
    • Informs ongoing research into minimal residual disease, late effects, and ethical considerations in pediatric leukemia treatment.